Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Short-term Investments (2020 - 2025)

Historic Short-term Investments for Legend Biotech (LEGN) over the last 6 years, with Q2 2025 value amounting to $70000.0.

  • Legend Biotech's Short-term Investments fell 9983.41% to $70000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $70000.0, marking a year-over-year decrease of 9983.41%. This contributed to the annual value of $70000.0 for FY2024, which is 8944.19% down from last year.
  • Legend Biotech's Short-term Investments amounted to $70000.0 in Q2 2025, which was down 9983.41% from $70000.0 recorded in Q1 2025.
  • In the past 5 years, Legend Biotech's Short-term Investments registered a high of $185.8 million during Q3 2023, and its lowest value of $70000.0 during Q4 2024.
  • For the 5-year period, Legend Biotech's Short-term Investments averaged around $83.7 million, with its median value being $50.0 million (2021).
  • Per our database at Business Quant, Legend Biotech's Short-term Investments skyrocketed by 425862340.43% in 2021 and then crashed by 9995.35% in 2025.
  • Quarter analysis of 5 years shows Legend Biotech's Short-term Investments stood at $1.4 million in 2021, then skyrocketed by 12753.39% to $185.6 million in 2022, then tumbled by 99.64% to $663000.0 in 2023, then plummeted by 89.44% to $70000.0 in 2024, then changed by 0.0% to $70000.0 in 2025.
  • Its last three reported values are $70000.0 in Q2 2025, $70000.0 for Q1 2025, and $70000.0 during Q4 2024.